SEC Form 5 · accession 0001214659-15-008504
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
May Liu
Officer — SVP, Finance & Administration
Period of report
Dec 31, 2015
Accepted (ET)
Dec 23, 2015 · 6:07 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2015 | A | 12,500 | $1.49 | A | 32,302 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 12,500 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan on June 30, 2015.